Ning, S., Ma, S., Saleh, A. Q., Guo, L., Zhao, Z., & Chen, Y. (2018). SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma. Gastroenterol Res Pract.
Citação norma ChicagoNing, Shanglei, Siquan Ma, Abdul Qahar Saleh, Lingyu Guo, Zixiao Zhao, and Yuxin Chen. "SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma." Gastroenterol Res Pract 2018.
MLA citiranjeNing, Shanglei, et al. "SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma." Gastroenterol Res Pract 2018.
Opozorilo: Ti citati niso vedno 100% točni.